Stock listing
MYD Stock Price, News, Filings & Events — Myriad Genetics, Inc.
Selected listing: MYD · GETTEX · EUR · DE
This page tracks Myriad Genetics, Inc.'s MYD:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MYD:GETTEX. MYD:GETTEX is the stock-level entry point for investors researching Myriad Genetics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Myriad Genetics, Inc. (ticker: MYGN) is a public company operating in the American market with a market capitalization of approximately $583.7 million. The company specializes in genetic testing and precision medicine, providing insights that help in the diagnosis and treatment of various health conditions. Myriad focuses on advancing healthcare through innovative genetic solutions.
- Ticker
- MYD:GETTEX
- Asset type
- Stock
- Market cap
- $289.8M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- GETTEX
- Currency
- EUR
Myriad Genetics, Inc. MYD:GETTEX stock context
This page tracks Myriad Genetics, Inc.'s MYD:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MYD:GETTEX. MYD:GETTEX is the stock-level entry point for investors researching Myriad Genetics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Myriad Genetics, Inc. (ticker: MYGN) is a public company operating in the American market with a market capitalization of approximately $583.7 million. The company specializes in genetic testing and precision medicine, providing insights that help in the diagnosis and treatment of various health conditions. Myriad focuses on advancing healthcare through innovative genetic solutions.
Latest news from Myriad Genetics, Inc.
Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference
August 27, 2026
Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Product...
July 30, 2026
Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026
July 23, 2026
Myriad Genetics Launches FirstGene® Multiple Prenatal Screen
July 21, 2026
New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer
July 2, 2026
Myriad Genetics, Inc. earnings calls
Myriad Genetics, Inc. (MYGN) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
Myriad Genetics, Inc. (MYGN) Q1 2026 Earnings Call
May 5, 2026 · Replay with transcript and chapters
Myriad Genetics, Inc. (MYGN) Q4 2025 Earnings Call
February 23, 2026 · Replay with transcript and chapters
Myriad Genetics, Inc. (MYGN) Q3 2025 Earnings Call
November 3, 2025 · Replay with transcript and chapters
Myriad Genetics, Inc. (MYGN) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Myriad Genetics, Inc. (MYGN) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Research Myriad Genetics, Inc.
Myriad Genetics, Inc. investor report
Review AI stock analysis and investor report context for MYD:GETTEX.
Myriad Genetics, Inc. company profile
View the public company page for Myriad Genetics, Inc. on 6ix.
Myriad Genetics, Inc. news
Read company news and market updates connected to Myriad Genetics, Inc..
Myriad Genetics, Inc. investor events
Find investor webinars, events, and replay context for Myriad Genetics, Inc..
Alternate listings
MYGN:NASDAQ
US · USD
Alternate listing for Myriad Genetics, Inc.; the primary context on this page is MYD:GETTEX.
897518:LS
DE · EUR
Alternate listing for Myriad Genetics, Inc.; the primary context on this page is MYD:GETTEX.
897518:LSX
DE · EUR
Alternate listing for Myriad Genetics, Inc.; the primary context on this page is MYD:GETTEX.
0K3W:LSE
GB · USD
Alternate listing for Myriad Genetics, Inc.; the primary context on this page is MYD:GETTEX.
MYD:FWB
DE · EUR
Alternate listing for Myriad Genetics, Inc.; the primary context on this page is MYD:GETTEX.
MYGN:BOATS
US · USD
Alternate listing for Myriad Genetics, Inc.; the primary context on this page is MYD:GETTEX.
MYD:HAN
DE · EUR
Alternate listing for Myriad Genetics, Inc.; the primary context on this page is MYD:GETTEX.
MYD:BX
CH · CHF
Alternate listing for Myriad Genetics, Inc.; the primary context on this page is MYD:GETTEX.
MYD:DUS
DE · EUR
Alternate listing for Myriad Genetics, Inc.; the primary context on this page is MYD:GETTEX.
MYD:HAM
DE · EUR
Alternate listing for Myriad Genetics, Inc.; the primary context on this page is MYD:GETTEX.
MYD:MUN
DE · EUR
Alternate listing for Myriad Genetics, Inc.; the primary context on this page is MYD:GETTEX.
MYD:SWB
DE · EUR
Alternate listing for Myriad Genetics, Inc.; the primary context on this page is MYD:GETTEX.